PREVALENCE OF GROWTH HORMONE DEFICIENCY & RANGES OF IGF-1 IN NORMAL ELDERLY
生长激素缺乏症的患病率
基本信息
- 批准号:7378259
- 负责人:
- 金额:$ 0.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Growth hormone is secreted by the pituitary gland and causes body growth during infancy, childhood, and adolescence. IGF-1 is a protein secreted by the liver in response to GH. IGF-1 mediates most of the actions of GH, so most physicians use IGF-1 as a marker for GH deficiency. This is a cross-sectional clinical study to determine the normal range for insulin growth factor-1 (IGF-1) in healthy individuals aged 50-90 and to determine whether low IGF-1 correlates with low growth hormone (GH) levels and establishes the diagnosis of GH deficiency in otherwise, healthy, elderly individuals. This project is being done in collaboration with the NYU Aging and Dementia Center.
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。生长激素由脑下垂体分泌,在婴儿期、儿童期和青春期促进身体生长。IGF-1是肝脏对生长激素的反应而分泌的一种蛋白质。胰岛素样生长因子-1介导了生长激素的大部分作用,因此大多数医生使用胰岛素样生长因子-1作为生长激素缺乏的标志物。这是一项横断面临床研究,旨在确定50-90岁健康人胰岛素生长因子-1(IGF-1)的正常范围,并确定低IGF-1是否与低生长激素(GH)水平相关,并在其他健康的老年人中建立GH缺乏的诊断。这个项目是与纽约大学老龄化和痴呆症中心合作完成的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L KLEINBERG其他文献
DAVID L KLEINBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L KLEINBERG', 18)}}的其他基金
SURGICAL DEBULKING PLUS OCTREOTIDE VERSUS OCTREOTIDE ALONE IN ACROMEGALY
肢端肥大症手术减瘤联合奥曲肽与单独奥曲肽的比较
- 批准号:
7378336 - 财政年份:2006
- 资助金额:
$ 0.42万 - 项目类别:
PREVALENCE OF GROWTH HORMONE DEFICIENCY & RANGES OF IGF-1 IN NORMAL ELDERLY
生长激素缺乏症的患病率
- 批准号:
7207079 - 财政年份:2005
- 资助金额:
$ 0.42万 - 项目类别:
Prevalence of Growth Hormone Deficiency & Ranges of IGF-1 in Normal Elderly
生长激素缺乏症的患病率
- 批准号:
6974297 - 财政年份:2004
- 资助金额:
$ 0.42万 - 项目类别:
LONG TERM SAFETY & EFFICACY OF LANREOTIDE FOR TREATMENT OF ACROMEGALICS
长期安全
- 批准号:
6305835 - 财政年份:1999
- 资助金额:
$ 0.42万 - 项目类别:
EFFECT OF RHGH ON ENDURANCE AND CARDIOPULMONARY FUNCTION IN GH DEFICIENT ADULTS
RHGH 对 GH 缺乏成人的耐力和心肺功能的影响
- 批准号:
6305956 - 财政年份:1999
- 资助金额:
$ 0.42万 - 项目类别:
NEW APPROACHES TO THE EARLY DIAGNOSIS/DETECTION OF RECURRENCE OF ACROMEGALY
肢端肥大症复发的早期诊断/检测新方法
- 批准号:
6115686 - 财政年份:1998
- 资助金额:
$ 0.42万 - 项目类别:
相似国自然基金
基于FP-Growth关联分析算法的重症患者抗菌药物精准决策模型的构建和实证研究
- 批准号:2024Y9049
- 批准年份:2024
- 资助金额:100.0 万元
- 项目类别:省市级项目
Research on the Rapid Growth Mechanism of KDP Crystal
- 批准号:10774081
- 批准年份:2007
- 资助金额:45.0 万元
- 项目类别:面上项目
相似海外基金
Elucidation of regulatory mechanisms of the growth hormone cytokinin and nitrogen dynamics in plant adaptation to nitrate fluctuation stress
阐明植物适应硝酸盐波动胁迫中生长激素细胞分裂素和氮动态的调节机制
- 批准号:
24K18138 - 财政年份:2024
- 资助金额:
$ 0.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Growth hormone regulating chondrocyte metabolism for osteoarthritis development
生长激素调节软骨细胞代谢促进骨关节炎的发展
- 批准号:
10730575 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Developing helical peptide antagonists of the growth hormone receptor
开发生长激素受体的螺旋肽拮抗剂
- 批准号:
10648820 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Central Mediation of Growth Hormone Effects in Humans
人类生长激素效应的中枢调节
- 批准号:
10659801 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE
人类生长激素接受者的克雅氏病监测
- 批准号:
10973401 - 财政年份:2023
- 资助金额:
$ 0.42万 - 项目类别:
Metabolomic Investigation of the Impact of Growth Hormone on Nonalcoholic Fatty Liver Disease: Identification of Novel Biomarkers and Therapeutic Targets
生长激素对非酒精性脂肪肝影响的代谢组学研究:新型生物标志物和治疗靶点的鉴定
- 批准号:
10451082 - 财政年份:2022
- 资助金额:
$ 0.42万 - 项目类别:
Metabolomic Investigation of the Impact of Growth Hormone on Nonalcoholic Fatty Liver Disease: Identification of Novel Biomarkers and Therapeutic Targets
生长激素对非酒精性脂肪肝影响的代谢组学研究:新型生物标志物和治疗靶点的鉴定
- 批准号:
10608193 - 财政年份:2022
- 资助金额:
$ 0.42万 - 项目类别:
Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure
生长分化因子 15 (GDF15) 作为一种新型心肌激素治疗心力衰竭
- 批准号:
10335004 - 财政年份:2022
- 资助金额:
$ 0.42万 - 项目类别:
Growth differentiation factor-15 (GDF15) as a novel myocardial hormone in heart failure
生长分化因子 15 (GDF15) 作为一种新型心肌激素治疗心力衰竭
- 批准号:
10557842 - 财政年份:2022
- 资助金额:
$ 0.42万 - 项目类别:














{{item.name}}会员




